Codon
SEPTEMBER 29, 2024
2028 Over the next year, the scientific community ferociously interrogated the model. On the surface, they hadn't deviated much from the early 2020s: a virus infected a cell and released the genetic therapy hidden within. The trained model also went live on HuggingFace , open for both academic and commercial usage.
The Pharma Data
SEPTEMBER 15, 2020
27 key programs highlighted, including assets that could potentially contribute revenue by 2025 and others in the 2026-2028 time frame. An update on Pfizer’s potential first-in-class maternal vaccine candidate for the prevention of respiratory syncytial virus (RSVpreF). BNT162 mRNA-based Vaccine Program. for RSV A and 18.0
Expert insights. Personalized for you.
Let's personalize your content